Skip to main content

Table 2 Timing, dosing, route of administration and technological supplies for peritoneal carcinomatosis assessment by ICG fluorescence

From: Indocyanine green fluorescence-guided intraoperative detection of peritoneal carcinomatosis: systematic review

Author Time (h before incision) Dose Route for ICG administration Camera system
Barabino [9] 24 h 0,25 mg/kg Intravenous Fluostick (Fluopics, Grenoble, France)
Liberale [10] 0 h (assessment after 5′-40′) 0,25 mg/kg Intravenous Photodynamic Eye, PDE (Hamamatsu Photonics, Japan)
Lieto [11] 0 h (assessment after 20′ (10′-30′) 0,25 mg/kg Intravenous Fluobeam (Fluoptics Imaging Inc, Cambridge, MA, USA),
Satou [12] 1–5 d (1 pts 24 d) 0, 5 mg/kg Intravenous PDE (Hamamatsu Photonics, Hamamatsu, Japan)
Tummers [13] 0 h (assessment after median 37′, max 141′) 20 mg Intravenous Mini-Fluorescence-Assisted Resection and Exploration (Mini-FLARE)
Veys [14] 0 h (assessment after 5′-360′, mean 60′) 0, 25 mg/kg Intravenous Photodynamic Eye, PDE (Hamamatsu Photonics, Japan)